Polyketide Synthase III isolated from uncultured deep-sea Proteobacterium from the Red Sea- functional and evolutionary characterization

Natural polyketide products are one of the major secondary metabolites produced among bacteria, fungi, and plants. They vary from flavonoids, pyrones, and stilbenes to phloroglucinols and resorcinols that are involved in important functions as antimicrobial activity, defense mechanisms and pigmentation. They are biosynthesized from acyl-CoA precursors by polyketides synthases (PKSs) that are categorized into 3 types: I, II and III. PKS type III is considered the simplest in its structure. It was believed that PKS type III was exclusively encoded by higher plants until the enduring efforts of bacterial genomes sequencing revealed the presence of more and more PKSs type III among them. There is an urge to investigate novel PKSs type III due to their promising polyketides of great biological and pharmaceutical advantages. This allowed metagenomic approaches to be a valuable tool to explore diverse environments for PKSs type III. Extreme environments as deep sea brine pools could probe unique natural polyketides capable of functioning in such conditions with valuable biotechnological and pharmaceutical applications. In this study, screening of the Lower Convective Layer (LCL) of Atlantis II (ATII) deep brine pool in the Red Sea was done. It identified sequences belonging to bacterial PKSs type III. A candidate encoding sequence was amplified from the environmental DNA. Functional annotations were assigned to the translated open reading frame including the conserved catalytic triad, domains, motifs and 3D modelling. Preliminary structural analysis showed well-fitted superimposition with the flowering plant Medicago sativa PKS type III crystal structure and predicted the interaction of the catalytic triad with the most common substrate malonyl-CoA. Further optimization of heterologous expression is required to investigate this isolated PKS type III functional activity. In an approach to gain better insights into the enzyme’s unresolved evolutionary origin, a comprehensive phylogenetic analysis was conducted. The analysis pinpoints the possible involvement of symbiotic bacterium Parachlamydia acanthamoebae in horizontal gene transfer events to eukaryotes. On the other hand, the sequence isolated from ATII brine pool was clustered in a clade with related PKSs type III sequences belonging to alpha-proteobacteria. Environmental assessment of PKSs type III abundance in ATII and nearby Discovery Deep (DD) brine pool revealed the presence of PKSs type III in ATII only, where most sequences were located in the LCL. This could be attributed to the high aromatic content within the brine as possible substrates for the enzyme. Based on these analyses, we could propose ATII microbial community as a unique source for natural polyketides

Exome-wide association study to identify rare variants influencing COVID-19 outcomes : Results from the Host Genetics Initiative

Publisher Copyright: Copyright: © 2022 Butler-Laporte et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Host genetics is a key determinant of COVID-19 outcomes. Previously, the COVID-19 Host Genetics Initiative genome-wide association study used common variants to identify multiple loci associated with COVID-19 outcomes. However, variants with the largest impact on COVID-19 outcomes are expected to be rare in the population. Hence, studying rare variants may provide additional insights into disease susceptibility and pathogenesis, thereby informing therapeutics development. Here, we combined whole-exome and whole-genome sequencing from 21 cohorts across 12 countries and performed rare variant exome-wide burden analyses for COVID-19 outcomes. In an analysis of 5,085 severe disease cases and 571,737 controls, we observed that carrying a rare deleterious variant in the SARS-CoV-2 sensor toll-like receptor TLR7 (on chromosome X) was associated with a 5.3-fold increase in severe disease (95% CI: 2.75–10.05, p = 5.41x10-7). This association was consistent across sexes. These results further support TLR7 as a genetic determinant of severe disease and suggest that larger studies on rare variants influencing COVID-19 outcomes could provide additional insights.Peer reviewe

Polyketide Synthase type III Isolated from Uncultured Deep-Sea Proteobacterium from the Red Sea – Functional and Evolutionary Characterization

<p>Screening and Isolation of possible bacterial PKS type III in Atlantis II deep brine pool in the Red Sea using a metagenomic approach and gaining deeper insights into the evolutionary origin of PKS type III among Prokaryotes and Eukaryotes</p

Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.

Host genetics is a key determinant of COVID-19 outcomes. Previously, the COVID-19 Host Genetics Initiative genome-wide association study used common variants to identify multiple loci associated with COVID-19 outcomes. However, variants with the largest impact on COVID-19 outcomes are expected to be rare in the population. Hence, studying rare variants may provide additional insights into disease susceptibility and pathogenesis, thereby informing therapeutics development. Here, we combined whole-exome and whole-genome sequencing from 21 cohorts across 12 countries and performed rare variant exome-wide burden analyses for COVID-19 outcomes. In an analysis of 5,085 severe disease cases and 571,737 controls, we observed that carrying a rare deleterious variant in the SARS-CoV-2 sensor toll-like receptor TLR7 (on chromosome X) was associated with a 5.3-fold increase in severe disease (95% CI: 2.75-10.05, p = 5.41x10-7). This association was consistent across sexes. These results further support TLR7 as a genetic determinant of severe disease and suggest that larger studies on rare variants influencing COVID-19 outcomes could provide additional insights

Exome-wide association study to identify rare variants influencing COVID-19 outcomes : Results from the Host Genetics Initiative

Publisher Copyright: Copyright: © 2022 Butler-Laporte et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Host genetics is a key determinant of COVID-19 outcomes. Previously, the COVID-19 Host Genetics Initiative genome-wide association study used common variants to identify multiple loci associated with COVID-19 outcomes. However, variants with the largest impact on COVID-19 outcomes are expected to be rare in the population. Hence, studying rare variants may provide additional insights into disease susceptibility and pathogenesis, thereby informing therapeutics development. Here, we combined whole-exome and whole-genome sequencing from 21 cohorts across 12 countries and performed rare variant exome-wide burden analyses for COVID-19 outcomes. In an analysis of 5,085 severe disease cases and 571,737 controls, we observed that carrying a rare deleterious variant in the SARS-CoV-2 sensor toll-like receptor TLR7 (on chromosome X) was associated with a 5.3-fold increase in severe disease (95% CI: 2.75–10.05, p = 5.41x10-7). This association was consistent across sexes. These results further support TLR7 as a genetic determinant of severe disease and suggest that larger studies on rare variants influencing COVID-19 outcomes could provide additional insights.Peer reviewe